JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
JNJ
186.77
-1.86%↓
ABT
126.59
-0.44%↓
MDT
93.37
-0.77%↓
VEEV
292.12
-1.14%↓
A
145.91
-0.57%↓
24h
Actual
Mínimo
22.21
Máximo
23.26
Ingresos | -14M -101M |
|---|---|
Ventas | 3K 75K |
Margen de beneficio | -134,313.333 |
Empleados | 143 |
EBITDA | -14M -100M |
Recomendaciones | Compra Fuerte |
|---|---|
Estimación a 12 meses | +71.89% upside |
Próximas Ganancias | 12 nov 2025 |
|---|
Capitalización de Mercado | 601M 2B |
|---|---|
Apertura anterior | 20.26 |
Cierre anterior | 23.07 |
By Acuity
50%
50%
154 / 373 Clasificación en Healthcare
By Trading Central
Confianza
Very Strong Bearish Evidence
12 / 13.14 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
28 oct 2025, 23:50 UTC
Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne
DJ
Leer
28 oct 2025, 23:25 UTC
SK Hynix Posts Record Earnings on Continued AI-Chip Demand
DJ
Leer
28 oct 2025, 23:18 UTC
Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update
DJ
Leer
28 oct 2025, 22:20 UTC
Visa Sales Jump as Consumers Keep Spending -- 2nd Update
DJ
Leer
28 oct 2025, 22:13 UTC
Wal-Mart de Mexico Net Profit Falls in 3Q
DJ
Leer
28 oct 2025, 21:38 UTC
Correction to Visa Sales Jump Article
DJ
Leer
28 oct 2025, 21:17 UTC
OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises
DJ
Leer
28 oct 2025, 21:07 UTC
Visa Sales Jump as Consumers Keep Spending -- Update
DJ
Leer
28 oct 2025, 21:02 UTC
Mondelez Tempers Outlook as Costs Rise
DJ
Leer
28 oct 2025, 23:51 UTC
Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk
DJ
Leer
28 oct 2025, 23:42 UTC
Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk
DJ
Leer
28 oct 2025, 23:02 UTC
SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026
DJ
Leer
28 oct 2025, 23:01 UTC
SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply
DJ
Leer
28 oct 2025, 22:46 UTC
SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE
DJ
Leer
28 oct 2025, 22:45 UTC
SK Hynix 3Q Net KRW12.6T >000660.SE
DJ
Leer
28 oct 2025, 22:44 UTC
SK Hynix 3Q Rev KRW24.44T >000660.SE
DJ
Leer
28 oct 2025, 22:43 UTC
SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus
DJ
Leer
28 oct 2025, 22:42 UTC
SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE
DJ
Leer
28 oct 2025, 22:40 UTC
SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE
DJ
Leer
28 oct 2025, 22:40 UTC
SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE
DJ
Leer
28 oct 2025, 22:22 UTC
Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ
DJ
Leer
28 oct 2025, 22:22 UTC
Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ
DJ
Leer
28 oct 2025, 22:22 UTC
Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ
DJ
Leer
28 oct 2025, 22:20 UTC
Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ
DJ
Leer
28 oct 2025, 22:02 UTC
Review & Preview: Earnings Extravaganza -- Barrons.com
DJ
Leer
28 oct 2025, 21:42 UTC
Global Equities Roundup: Market Talk
DJ
Leer
28 oct 2025, 21:42 UTC
Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk
DJ
Leer
28 oct 2025, 21:20 UTC
Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year
DJ
Leer
28 oct 2025, 21:19 UTC
Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year
DJ
Leer
28 oct 2025, 21:18 UTC
Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 38.09 USD 71.89%
Máximo 61 USD
Mínimo 14.073 USD
De acuerdo con 14 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.
By TipRanks
Compra Fuerte
14 ratings
13
Comprar
1
Mantener
0
Vender
De acuerdo con 14 analistas que ofrecen calificaciones bursátiles a para VIRIDIAN THERAPEUTICS INC Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Very Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Medio plazo
Bearish Evidence
All events are bearish.
Largo Plazo
Strong Bearish Evidence
All events are bearish.
By Acuity
Noticias sobre sentimiento de mercado
Neutral
Volatilidad
Por debajo de la media
Volumen de Noticias (RCV)
Media
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$